Beta Medicine Won Second Prize of 2021 Invention and Innovation Award

Release time:

2022-01-05

Recently, the China Invention Association announced the evaluation results of the 2021 Invention and Entrepreneurship Award Innovation Award, and Wuxi Beta Pharmaceutical Technology Co., Ltd.'s "Development and Tracer Application of C14 Isotope Labeling Technology" project was evaluated.Second Prize in Medicine and Health.

The "Invention and Entrepreneurship Award Innovation Award" of the China Invention Association was approved by the Ministry of Science and Technology in 2005 and was established by the China Invention Association. This award has a wide range of social influence and authority in the field of invention and innovation across the country. Its sub-awards "Entrepreneurship Award" and "Innovation Award" are qualified to nominate the National Technology Invention Award and the National Science and Technology Progress Award, and the gold content is very high.

This award-winning achievement of Beta Pharmaceuticals is mainly used to label small molecule drugs and pesticides or bioactive molecules for pharmacokinetics, clinical, environmental and disease detection research. In the field of C14 marking products and tracer technology, the project has solved the situation that C14 marking of innovative medicines and pesticides in China is sent to foreign countries for doing. It has provided C14 marking technology services for dozens of listed companies, industry leaders and scientific research institutes. It has been well received by customers and has greatly promoted the development of innovative medicines and pesticides in China.